Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 58

    Recipharm plans to launch RedHill helicobacter pylori infection drug Talicia in Q1 2020

    Recipharm plans to launch RedHill helicobacter pylori infection drug Talicia in Q1 2020

    Medical Dialogues Bureau3 Dec 2019 9:15 AM IST
    New Delhi: Recipharm, the contract development and manufacturing organisation (CDMO), announced recently ongoing large-scale commercial manufacturing...
    Alembic Pharma JV Aleor gets tentative USFDA nod for therapeutic equivalent of Pennsaid Topical Solution

    Alembic Pharma JV Aleor gets tentative USFDA nod for therapeutic equivalent of Pennsaid Topical Solution

    Farhat Nasim2 Dec 2019 3:43 PM IST
    The approved ANDA(Diclofenac Sodium Topical Solution) is therapeutically equivalent to the reference listed drug product (RLD), Pennsaid Topical...
    Jubilant Life Sciences arm expands drug discovery services biz in Greater Noida, Bengaluru

    Jubilant Life Sciences arm expands drug discovery services biz in Greater Noida, Bengaluru

    Medical Dialogues Bureau2 Dec 2019 3:35 PM IST
    Due to growing customer demand for its range of functional and integrated drug discovery services, Jubilant Biosys(Bengaluru-based subsidiary of...
    Sun Pharma updates on Ranbaxy Generic Drug Application Antitrust Litigation in US

    Sun Pharma updates on Ranbaxy Generic Drug Application Antitrust Litigation in US

    Farhat Nasim2 Dec 2019 11:28 AM IST
    On November 27, 2019, the US District Court (District of Massachusetts) entered a decision denying in part and granting in part Sun Pharma Ltd’s...
    Biocon arm Syngene names Sibaji Biswas as new Chief Financial Officer

    Biocon arm Syngene names Sibaji Biswas as new Chief Financial Officer

    Medical Dialogues Bureau2 Dec 2019 9:35 AM IST
    Sibaji Biswas will succeed M.B. Chinappa, current CFO, who will stay within the Biocon Group of Companies and join Biocon Biologics India Ltd. in a...
    Suven Life Sciences Alzheimers drug Masupirdine fails to meet primary endpoint

    Suven Life Sciences Alzheimers drug Masupirdine fails to meet primary endpoint

    Medical Dialogues Bureau2 Dec 2019 9:30 AM IST
    SUVN-502 did not meet the pre-specified primary endpoint. Meaningful improvements and potential beneficial effects on cognitive function, behavioural...
    China plans to use bulk-buy scheme to close pharmaceutical price gap

    China plans to use bulk-buy scheme to close pharmaceutical price gap

    Medical Dialogues Bureau2 Dec 2019 9:00 AM IST
    New Delhi: China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets,...
    Eli Lilly to invest USD 400 million in Indianapolis facilities

    Eli Lilly to invest USD 400 million in Indianapolis facilities

    Medical Dialogues Bureau1 Dec 2019 9:30 AM IST
    New Delhi: Eli Lilly and Company recently announced plans to invest $400 million in its manufacturing facilities at its Lilly Technology Center campus...
    Bayer collaborates with Pharmaron to develop new molecular entities for veterinary medicines

    Bayer collaborates with Pharmaron to develop new molecular entities for veterinary medicines

    Farhat Nasim1 Dec 2019 9:22 AM IST
    New Delhi: Bayer and Pharmaron have entered into a global collaboration agreement to develop new molecular entities for veterinary medicines.Under the...
    Neuraxpharm expands operation in Southern Europe with launch of Neuraxpharm Portugal

    Neuraxpharm expands operation in Southern Europe with launch of Neuraxpharm Portugal

    Medical Dialogues Bureau1 Dec 2019 9:00 AM IST
    Neuraxpharm aims to build its position as a CNS specialist in Portugal offering its wide portfolio of branded and consumer healthcare products in the...
    Health Ministry appoints 12 analysts pan India for different classes of drugs; Details

    Health Ministry appoints 12 analysts pan India for different classes of drugs; Details

    Medical Dialogues Bureau30 Nov 2019 2:58 PM IST
    New Delhi: Through a recent Gazette notification, the Union Health Ministry has announced the appointment of Government Analysts in pan India in...
    Aurobindo Pharma to acquire Profectus BioSciences biz assets for Rs 80 crore

    Aurobindo Pharma to acquire Profectus BioSciences biz assets for Rs 80 crore

    Medical Dialogues Bureau30 Nov 2019 9:45 AM IST
    Auro Vaccines LLC is a wholly-owned subsidiary of Aurobindo Pharma USA Inc, USA, which is a wholly-owned arm of the company, Aurobindo Pharma said in...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    French court dismisses damage claims against Merck over Levothyrox

    French court dismisses damage claims against Merck over Levothyrox

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok